BeOne Medicines (ONC) net income: $287M
BeOne Medicines reported a net income of $287M for the year ended Dec 31, 2025.
From BeOne Medicines's filings with the SEC · Read the filing · ONC stock page
BeOne Medicines net income by year
#820 of 3,748 US companies by net income · See the full ranking
| Year ended | Net income | Change |
|---|---|---|
| Dec 31, 2025 | $287M | – |
| Dec 31, 2024 | −$645M | – |
| Dec 31, 2023 | −$882M | – |
| Dec 31, 2022 | −$2B | – |
| Dec 31, 2021 | −$1.5B | – |
Net income of similar companies
Companies in the same industry as BeOne Medicines, by SEC industry code, with the closest net income. Each name opens the same page for that company.
| Company | Net income, latest year | Year ended |
|---|---|---|
| Acadia Pharmaceuticals | $391M | Dec 31, 2025 |
| Rigel Pharmaceuticals | $367M | Dec 31, 2025 |
| Biomarin Pharmaceutical | $349M | Dec 31, 2025 |
| Alnylam Pharmaceuticals | $314M | Dec 31, 2025 |
| Aurinia Pharmaceuticals | $287M | Dec 31, 2025 |
| BeOne Medicines | $287M | Dec 31, 2025 |
| Alkermes | $242M | Dec 31, 2025 |
Questions and answers
What is BeOne Medicines's net income?
BeOne Medicines reported a net income of $287M for the year ended Dec 31, 2025.
Numbers as reported in BeOne Medicines's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology